Bioequivalence Study for Terbinafine 250 mg
Clinical trial NCT01772212 · COMPLETED
Trial details
- NCT number
- NCT01772212
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-24
- Primary completion
- 2011-03-15
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.